Article 32 3

3.   Within two years of completing the human biomonitoring study referred to in Article 25, the Commission shall assess the appropriateness of requiring the ECHA and the EFSA, in cooperation with the EEA, to commission regular human biomonitoring studies, as well as the resources necessary for such studies and the practical arrangements for involving Member States in such studies.

On the basis of that assessment the Commission may present a legislative proposal.